Transient right ventricular hyperthophy in a newborn infant exposed in utero to nimesulide;Ipertrofia ventricolare destra transitoria in un neonato esposto in utero a nimesulide

Minerva Pediatrica

Volumn 57, Issue 5, 2005, Pages 313-318

  Sciacca, P ^a   Romeo, M G ^a   Falsaperla, R ^a   Mattia, C ^a   Betta, P ^a   Tornambene, G ^a   Distefano, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Infant, newborn; Nimesulide; Pulmonary hypertension; Right ventricular hypertrophy

Indexed keywords

CYCLOOXYGENASE 2; NIMESULIDE;

ARTICLE; CHILDBIRTH; CONTROLLED STUDY; DRUG USE; DUCTUS ARTERIOSUS; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; MOTHER; NEWBORN; OUTCOMES RESEARCH; PREGNANCY; PULMONARY HYPERTENSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SULFONAMIDES; TIME FACTORS;

EID: 28244452846     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rein AJ, Nadjari M, Eichalal U, Nir A. Contraction of the fetal ductus arteriosus induced by diclofenac. Case report. Fetal Diagn Ther 1999;14:24-5.
2. Talati AJ, Salim MA, Korones SB. Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report. Am J Perinatol 2000;17:69-71.
3. Sawdy R, Slater D, Fisk N, Edmonds DK, Bennet P. Use of a cyclo-oxygenase type-2-selective non steroidal antinflammatory agent to prevent preterm delivery. Lancet 1997;350:265-6.
4. Locatelli A, Vergani P, Bellini P, Strobel N, Ghidini A. Can a cyclooxigenase type-2-selective tocolytic agent avoid the fetal side effects of indomethacin? BJOG 2001;108:325-6.
5. Chao RC, Ho ES, Hsieh KS. Doppler echocardiographic diagnosis of intrauterine closure of the ductus arteriosus. Prenat Diagn 1993;73:989-94.
6. Leal SD, Cavalle-Garrido T, Ryan G, Farine D, Heilbut M, Smallhorn JF. Isolated ductal clousure in utero diagnosed by fetal echocardiography. Am J Perinatol 1997;14:205-10.
7. Levin DL, Mills LI, Weinberg AG. Haemodynamic, pulmonary vascular and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. Circulation 1979;60:360-4.
8. Hofstadler G, Tulzer G, Altmann R, Schmitt K, Danford D, Huhta JC. Spontaneous clousure of the human fetal ductus arteriosus-A cause of fetal congestive hearth failure. Am J Obstet Gynecol 1996;174:879-83.
9. Geggel RL, Reid LM. The structural basis of PPHN. Clin Perinat 1984;11:525-49.
10. Mielke G, Peukert U, Krapp M, Schneider-Pungs J, Gembruch U. Fetal and transient neonatal right heart dilatation with severe tricuspid valve insufficiency in association with abnormally S-shaped kinking of the ductus arteriosus. Ultrasound Obstet Gynecol 1995;3:338-41.
11. Distefano G, Romeo MG, Parisi MG, Magro G. Aspetti fisiopatologici e terapeutici della persistenza della circolazione fetale. Revisione della letteratura ed osservazioni istologiche personali. Ped Med Chir 1992;14:387-98.
12. Turner GR, Levin DL. Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn. Clin Perinat 1984;11:581-9.
13. Bonayad A, Bermier SG, Asselin P, Bhattacharya M, Chemtob S et al. Characterization of PGE2 receptors in fetal and newborn ductus arteriosus in the pig. Sem Perinatol 2001;25:70-5.
14. Mielke G, Steil E, Breuer J, Goelz R. Circulatory changes following intrauterine closure of the ductus arteriosus in the human fetus and newborn. Prenat Diagn 1998;18:139-45.
15. Murphy JD, Rabinovitch M, Goldstein JD. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 1981;98:962-7.
16. Rabinovitch M. New developments in the pathogenesis of pulmonary hypertension in the newborn and child. Acta Paediatr Jpn 1989;31:631-40.
17. Rosemberg AA, Kennaugh J, Koppenafer SL, Loomis M, Chaffeld BA, Abman SH. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993;123:109-14.
18. Distefano G. [The newborn with cardiological problems. The dilemma between malformative and non-malformative pathology] Minerva Pediatr 2003;55:109-20. Italian.
19. Simbi KA, Secchieri S, Rinaldo M, Demi M, Zanardo V. In utero ductal closure following near-term mater self medication with nimesulide and acetaminophen. J Obstet Gynaecol 2002;22:440-1.
20. Slater D, Dennes W, Sawdy R, Allport V, Bennett P. Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol 1999;22:125-30.
21. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclo-oxygenase II. Nature 1995;378:406-9.
22. Prèvot A, Mosig D, Martini S, Guignard JP. Nimesulide, a cyclo-oxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit. Pediatr Res 2004;55:254-60.
23. Holmes RP, Stone PR. Severe oligohydramnios induced by cyclo-oxygenase -2 inhibitor nimesulide. Obstet Gynecol 2000;96:810-1.
24. Landau D, Shelef I, Polachek H, Marks K, Holcberg G. Perinatal vasoconstrictive renal insufficiency associated with maternal nimesulide use. Am J Perinatol 1999;16:441-4.
25. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxigenase-type-2 selective inhibitor nimesulide as tocolytic. Lancet 1999;354:1615.
26. Csaba IF, Sulyok E, Ertl T. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome. J Pediatr 1978;92:484.
27. Levin DL, Fixler DE, Morris FC, Tyson J. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr 1978;92:478-83.
28. Wilkinson AR, Aynsley-Green A, Mitchell MD. Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. Arch Dis Child 1979;54:942-5.
29. Dalens B, Dechelotte P, Gaulme J, Raynaud EJ. [Maternal treatment with indomethacin and severe neonatal pulmonary hypertension] Arch Fr Pediatr 1981;38:261-5. French.
30. Schoenfeld A, Bar Y, Merlob P, Ovadia Y. NSAIDs: Maternal and fetal considerations. Am J Reprod Immunol 1992;28:141-7.